Life Science is already delivering actual drug candidates within a year by using HPC in general, and BioExcel codes in particular. BioExcel helps accelerate this development. The BioExcel-3 strategy to achieve significant impact relies on (i) ensuring that these codes provide high performance, efficiency, scaling, reliability and quality to meet academic and industrial needs; (ii) identifying user needs to prioritise development of features and performance; (iii) providing state-of-the-art training program for next-generation EU workforce on new methods; (iv) being the preferred EU partner for international organisations; (v) providing sustainable business paths for companies that need commercial support or want to fund development of specific features; and (vi) operating under an open governance model. BioExcel-3 will grow and sustain the Life Science HPC community in Europe.

2023

2026